Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The amended agreement, announced July 30, 2026, is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This expansion is significant for business leaders and technology executives as it signals a shift toward decentralized, patient-owned health data ecosystems. By integrating blockchain with AI-driven remote monitoring and IoT population health, Datavault AI is positioning itself at the intersection of healthcare, data monetization, and Web3. The move could empower patients to control and monetize their own health data, potentially disrupting traditional healthcare data ownership models and creating new revenue streams for healthcare providers, insurers, and technology firms.
Datavault AI’s platform leverages its Acoustic Sciences and Data Sciences divisions. The Acoustic Sciences division features WiSA, ADIO and Sumerian patented technologies for spatial and multichannel wireless sound transmission, while the Data Science division focuses on Web3 and high-performance computing for data valuation and secure monetization. The company’s Information Data Exchange enables Digital Twins and the licensing of name, image and likeness by securely attaching physical real-world objects to immutable metadata. The company is headquartered in Philadelphia, PA.
The global health and wellness market’s rapid expansion makes this agreement timely. As healthcare increasingly digitizes, the ability to securely tokenize real-world health assets and enable patient-controlled access could reduce friction in data sharing, improve clinical outcomes, and unlock new value from health data. For industries like biotech, fintech, and insurance, this development may herald new models for data licensing and patient engagement.
For more details, the full press release is available at https://ibn.fm/vBAxH. Additional information about Datavault AI can be found at https://dvlt.ai.
